EdTech Insight – Modernizing the biopharma commercial model to maximize patient value

by EdTechMate | Mar 20, 2024 | McKinsey, News & Insights

Executive Summary and Main Points In the realm of international education, the biopharmaceutical industry’s challenges and adaptive strategies provide valuable insights. Central to the current transformation is the departure from traditional sales-driven models...

EdTech Insight – Redesigning for speed: Addressing life cycle compression in biopharma

by EdTechMate | Mar 14, 2024 | McKinsey, News & Insights

Executive Summary and Main Points The recent industry report underscores significant shifts in the biopharma landscape characterized by heightened competition, rapid treatment advancements, growing biosimilar adoption, and payer pressures. Innovations are necessitated...

EdTech Insight – What to expect from medtech in 2024

by EdTechMate | Feb 7, 2024 | McKinsey, News & Insights

“`html Executive Summary and Main Points The medtech industry experienced an uneven trajectory in 2023, balancing between significant revenue growth, high novel-product approvals, and strategic divestitures, against investor shifts from obesity-related-device...

EdTech Insight – Here to stay: An attractive future for medical aesthetics

by EdTechMate | Feb 1, 2024 | McKinsey, News & Insights

Executive Summary and Main Points The medical-aesthetics industry, buoyed by increased social media acceptance and technological advancements, is on a high growth trajectory with an expected annual increase of up to 14 percent through 2026. The resilience of this...

EdTech Insight – Accelerating clinical trials to improve biopharma R&D productivity

by EdTechMate | Jan 22, 2024 | McKinsey, News & Insights

Executive Summary and Main Points The biopharmaceutical (biopharma) R&D sector is experiencing a pivotal shift where innovation is no longer hindered by science or funding but by the pace of clinical trial completions due to participant and staff shortages. The...